Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Apply
Methotrexate, Erlotinib, Celecoxib
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step